How To Reduce Patient Dropout Rates In Clinical Trials

Patient dropout represents a significant financial and operational risk, with industry rates climbing as high as 40%. To prevent attrition, sponsors must shift from reactive troubleshooting to proactive protocol design that minimizes participant burden.

The primary drivers of dropout include travel friction, rigid scheduling, and complex assessment windows. Prevention begins with a structured retention plan that identifies high-burden visits before enrollment starts. Effective strategies include adopting hybrid or decentralized models to reduce site visits and treating communication as a high-priority service. Special care must be taken with ocular endpoints, which often introduce "hidden burden" through lengthy imaging or specialized scheduling. By consolidating these assessments into existing visits or utilizing mobile clinical solutions, sponsors can significantly lower the friction that leads to disengagement. Ultimately, retention success relies on using data—such as missed visit rates and reschedule frequencies—as an early warning system.